Table 2:

Outcomes of COVID-19 Patients

	Total (N=39)	IMV-alone (N=21)	RVAD/ECMO (N=18)	p-value
In hospital mortality	13 (33.3%)	11 (52.4%)	2 (11.1%)	.008
30-day Mortality	10 (25.6%)	9 (42.9%)	1 (5.6%)	.011
ICU LOS (days)	13 (6 – 27) (N=37)	11.5 (6 – 22.5) (N=20)	21 (9 – 36) (N=17)	.067
Post-intubation ICU days	12 (6 – 27) (N=37)	8.5 (5.5 – 22.5) (N=20)	16 (9 – 27) (N=17)	.17
Hospital LOS (days)	18 (9 – 36)	14 (8 – 29)	25.5 (17 – 39)	.054
Post-intubation hospital days	16 (8 – 32)	9 (6 – 27)	20 (11 – 40)	.14
Duration of mechanical ventilation (days)	7.5 (1 – 22) (N=26)	10 (5 – 20) (N=10)	5 (1 – 34) (N=16)	.44
Acute kidney injury	15 (38.5%)	15 (71.4%)	0 (0%)	<.001
Tracheostomy	10 (27.0%) (N = 37)	3 (14.3%) (N=21)	7 (43.8%) (N=16)	.067

IMV, invasive mechanical ventilation; RVAD/ECMO, right ventricular assist device/extracorporeal membrane oxygenation; ICU, intensive care unit; LOS, length of stay